CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
SINGLE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
42.8%
This updated advisory is a follow-up to the original advisory titled ICSA-19-248-01 BD Pyxis that was published September 5, 2019, on the ICS webpage on us-cert.gov.
Successful exploitation of this vulnerability could allow the Active Directory (AD) credentials of a previously authenticated user to gain access to the device. This could result in an attacker having the same level of privilege previously granted to a user prior to account expiration, and could allow access to patient data and medications. For exploitation to occur, products must be actively using AD for login and be connected to the hospital domain. Users who do not use AD are not impacted by this vulnerability.
The following versions of BD Pyxis, a medication management platform, are affected:
--------- Begin Update A Part 1 of 2 ---------
--------- End Update A Part 1 of 2 ---------
A vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.
CVE-2019-13517 has been assigned to this vulnerability. A CVSS v3 base score of 7.6 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
BD reported this vulnerability to CISA.
--------- Begin Update A Part 2 of 2 ---------
BD notes that connecting medication dispensing cabinets to a hospital domain is an uncommon configuration and is not recommended. BD reports this vulnerability was remediated in the latest software release; however, BD has been unsuccessful in reproducing this issue since initially testing and reproducing it earlier in the year. BD recommends the following mitigations and compensating controls to reduce risk associated with this vulnerability:
--------- End Update A Part 2 of 2 ---------
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on us-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
CISA also recommends users take the following measures to protect themselves from social engineering attacks:
No known public exploits specifically target this vulnerability.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2019-13517
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01
cwe.mitre.org/data/definitions/384.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=BD%20Pyxis%20%28Update%20A%29+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01&title=BD%20Pyxis%20%28Update%20A%29
www.fda.gov/medical-devices/digital-health/cybersecurity
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01
www.oig.dhs.gov/
www.us-cert.gov/ics
www.us-cert.gov/ics
www.us-cert.gov/ics/recommended-practices
www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B
www.us-cert.gov/ncas/tips/ST04-014
www.us-cert.gov/sites/default/files/publications/emailscams_0905.pdf
www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=BD%20Pyxis%20%28Update%20A%29&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
SINGLE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
42.8%